Find the right fit for you - faster
Get tailored insights about working at Radius Health in one quick step.
Radius Health Snapshot
Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the area of bone health. Our team works collaboratively and relentlessly to advance our therapies with the goal of improving the lives of patients, their families, and their caregivers. The Radius portfolio consists of commercial and clinical development assets that include mid to late-stage drug candidates.
We are dedicated to serving those patients suffering from bone loss like the 8.9 million osteoporotic fractures that occur annually worldwide. In 2017, we launched our first commercial product in the U.S., TYMLOS® (abaloparatide injection), for the treatment of postmenopausal women with osteoporosis at high risk for fracture. In 2022, Radius announced the FDA approval to expand TYMLOS® (abaloparatide injection) as a treatment to increase bone density in men with osteoporosis at high risk of fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture), or patients who have failed or are intolerant to other available osteoporosis therapy.
If you are seeking to become part of our outstanding team of professionals, we invite you to apply online today. For more information visit https://radiuspharm.com/
Radius is an Equal Opportunity Employer.
We are dedicated to serving those patients suffering from bone loss like the 8.9 million osteoporotic fractures that occur annually worldwide. In 2017, we launched our first commercial product in the U.S., TYMLOS® (abaloparatide injection), for the treatment of postmenopausal women with osteoporosis at high risk for fracture. In 2022, Radius announced the FDA approval to expand TYMLOS® (abaloparatide injection) as a treatment to increase bone density in men with osteoporosis at high risk of fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture), or patients who have failed or are intolerant to other available osteoporosis therapy.
If you are seeking to become part of our outstanding team of professionals, we invite you to apply online today. For more information visit https://radiuspharm.com/
Radius is an Equal Opportunity Employer.
